Outlook

The foreign exchange calendar is light on events scheduled for Monday and Tuesday. On Tuesday, traders will be watching the US existing home sales data and the Richmond manufacturing index. On Wednesday, focus shifts to the spot services…

Upcoming Events:Monday:PBoC LPR.Wednesday:Spot PMIs for Japan/Australia/Eurozone/UK/US, Bank of Canada monetary policy decision.ThursdayUS durable goods orders, US jobless claims, US Q2 GDP advance.FridayTokyo Consumer Price Index, US…

Press release from Euronet (NASDAQ: EFT): Non-GAAP EPS for the second quarter was $2.25. Error by $0.04. Revenue of $986.2 million (+5.0% year-over-year) Fails by $23.8 million. Adjusted EBITDA was $178.2 million, an increase of 7%…

Netflix (NFLX) reported second-quarter earnings on Thursday, initially sending the stock down 6% in after-hours trading after the streaming giant’s revenue forecast fell short of Wall Street’s expectations for the current quarter. But…

Abbott Park, Illinois - Abbott Laboratories The American healthcare company (NYSE:) reported second-quarter earnings that beat Wall Street expectations and raised its full-year adjusted earnings guidance, signaling confidence in its…

By Rajesh Kumar Singh CHICAGO (Reuters) - United Airlines Holdings Inc on Wednesday forecast lower-than-expected profit in the current quarter as the industry grapples with a surplus of seat capacity in the domestic market that has…

About the companyDollar General Corporation (NYSE:), a leader in the U.S. discount retail sector, continues to operate in a complex market environment. Its extensive network of more than 14,000 stores offers a broad range of products,…

Upcoming Events:Monday:New Zealand Services PMI, People's Bank of China MLF, China Industrial Production and Retail Sales, Eurozone Industrial Production, Bank of Canada Business Expectations Survey, Fed Chair Powell. Tuesday:Eurozone ZEW…

SlavkoSereda/iStock via Getty Images Oil futures gave up early gains and settled lower on Friday, capping off the first weekly loss after four straight positive weeks, as the recent rally in prices allowed traders to to exit their…

On Monday, Raymond James changed its stance on Gilead Sciences Inc. (NASDAQ:GIL) stock, upgrading it from “market perform” to “outperform.” The firm also set a $93.00 price target for the biopharmaceutical company. This update is bolstered…